Aeon Pharmaceuticals wins 1st place in the Pitch Competition of the Bio Executive Forum
Aeon Pharmaceuticals , a Jerusalem company, is developing a detoxification antidote to treat ER (Emergency Room) patients for alcohol poisoning. Alcohol abuse is a global epidemic.
BioFeed launched novel solutions for pest-control during PM’s Modi and Netanyahu visit
July 6 2017 – Biofeed launched a novel solution to the Bactrocera dorsalis and Bactrocera zonata fruit flies during a visit by Indian Prime Minister Modi and
Congratulations to Anan Copty, Butros Hallac, and NIMD on getting awarded a CIIRDF grant
NIMD, Non Invasive Medical Devices, a Jerusalem-based medical device startup company focused on the treatment of cancer, has been awarded a grant by the Canada-Israel
Gamida Cell Ltd closes today $40 million financing!
Jerusalem based Gamida Cell Ltd., a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, announced today that they have
Brainsway’s deep-TMS study in Obsessive Compulsive Disorder (OCD) Patients produces positive final results
Brainsway, located in Jerusalem, is preparing a submission to the FDA to market the device for Obsessive Compulsive Disorder (OCD) . Its deep-TMS treatment led to statistically
Betalin Therapeutics is working to cure diabetes by making Micro-Pancreases
Betalin Therapeutics is developing an Engineered Micro Pancreas (EMP) to improve the quality of life for millions of people with diabetes. Betalin Therapeutics, founded by
6Degrees is looking for pilot trial candidates to try out their new device controls digital devices for people who have lost their hand dexterity
6Degrees has developed a smart band that allows people who have lost their hand dexterity full control of digital smart devices, such as smart phones,
JLM based Entera Bio files for Nasdaq IPO
Entera Bio, a portfolio company of DNA Biomedical Solutions Ltd. (TASE: DNA) located in Jerusalem, has announced the filing of a draft prospectus with the
Jerusalem based Oramed to dual list on TASE
Jerusalem based Oramed Pharmaceuticals Inc. (Nasdaq:ORMP), which develops orally administered drugs as a substitute for injections, has announced that the Israel Securities Authority has authorized the
